The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who...
Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol...
The vast majority (89%) of police officers surveyed said they believed they would benefit from more training on medical cannabis.
A daily dose of more than 4.7mg ‘significantly prolonged' survival time and also improved quality of life.
Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders.
Sponsored The international Cannabis scene dazzles aficionados with its variety of UK cannabis strains. Connoisseurs remain on a quest, aiming to discover cannabis strains that offer...
The latest UK research points to the potential benefits of medical cannabis in two long-term conditions.
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to ‘unusually high’...
The UK’s Food Standards Agency (FSA) has issued the first two ‘positive safety assessments’ for CBD (cannabidiol) products as part of its years-long novel foods authorisation...
“Our data suggests that you can be hard-working, motivated and a chronic cannabis user at the same time.”
The UK’s first international prescribing service has launched for medical cannabis patients travelling to the country from overseas.
New findings suggest promise for CBN in treating neurological disorders like traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease.
